Crossmark

A randomized trial to compare procalcitonin and C-reactive protein in assessing severity of sepsis and in guiding antibacterial therapy in Egyptian critically ill patients

Crossref DOI link: https://doi.org/10.1007/s11845-020-02494-y

Published Online: 2021-01-14

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ali, Walid A.

Bazan, Naglaa S. https://orcid.org/0000-0002-8930-4697
Elberry, Ahmed A.

Hussein, Raghda R. S.
License Information

Text and Data Mining valid from 2021-01-14

Version of Record valid from 2021-01-14
More Information

Article History

Received: 1 September 2020

Accepted: 19 December 2020

First Online: 14 January 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study is self-funded.

Document is current

Any future updates will be listed below